Popular Drug Recall Affects Thousands of Consumers

April 3rd, 2012 at 4:09 am

The Food and Drug Administration (FDA) is has issued a warning regarding a mix-up at a Novartis manufacturing plant based in Lincoln, Nebraska, according to BusinessWeek. In what’s sure to spark an influx of personal injury suites against the drug giant, a massive recall of 1,645 lots of over-the-counter drugs was issued, including well-known brands Execdrin, Bufferin, NoDoz, and Gas-X. The recall was issued only after the company, according to BusinessWeek, “received hundreds of complaints of broken and chipped pills and inconsistent bottle packaging that could cause pills to be mixed up.” FDA officials said that some of these could have been accidentally packaged with powerful prescription drugs made at the same facility, several of which belong to the opiate family.

Image from compositesw.com.

This isn’t the first time that the Switzerland-based drug manufacturer Novartis has come under fire from the FDA. In December 2011, fiercepharma.com reported that the giant had received repeated notices of violations, including crystallization problems of an injectable drug, repeated instances of inadequate equipment cleaning, and inadequate process violation for several products.

Drug mix-ups and pill recalls are common personal injury suites, but that doesn’t mean they’re easy to file or lack complex proceedings. If you or someone you know has been affected by the Novartis recall—or any other that has lead to personal injury or mental suffering—don’t go through the process alone. Contact the law offices of Francis J. Discipio today. We have the experience and expertise to win your case and help you and your loved ones to move on.


Written by Staff Writer

April 3rd, 2012 at 4:09 am

Back to Top Back to Top Back to Top